Enanta Pharmaceuticals Inc. sell StockNews.com
Start price
30.09.23
/
50%
€10.70
Target price
30.09.24
-
Performance (%)
-10.75%
End price
01.10.24
€9.55
Summary
This prediction ended on 01.10.24 with a price of €9.55. The prediction for Enanta Pharmaceuticals Inc. closed with a convincing performance of -10.75%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Enanta Pharmaceuticals Inc. | -6.364% | -6.364% | 88.991% |
| iShares Core DAX® | -1,74 % | -10,68 % | -0,89 % |
| iShares Nasdaq 100 | -2,58 % | -3,32 % | 11,12 % |
| iShares Nikkei 225® | -1,16 % | -9,36 % | 23,69 % |
| iShares S&P 500 | -1,42 % | -3,76 % | 7,19 % |
Comments by StockNews_com for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ENTA provided by MarketBeat
In the thread Trading Enanta Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€15.20
06.04.24
06.04.24
-
06.04.25
06.04.25
-72.89%
07.04.25
07.04.25
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.00
02.09.23
02.09.23
-
02.09.24
02.09.24
-14.62%
03.09.24
03.09.24